Tiziana Life Sciences Ltd (TLSA) income statement
TLSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on May 1, 2026Score 3/30
$0.65+0.07 (+12.07%)
Close on Nov 17, 2026Market cap $78.33MP/E –Yield –
Tiziana Life Sciences Ltd income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 0.76
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 35.8%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?